Skip to main content

Table 1 Summary of baseline subject characteristics

From: Sugammadex or neostigmine for reversal of neuromuscular block on the quality of postoperative recovery in elderly adults undergoing video-assisted thoracoscopic lobectomy: a randomised controlled trial

Variables

Sugammadex (n = 39)

Neostigmine (n = 38)

P-value

 

Age (yr)

72 (68–75)

69 (67.75–74)

0.256

 

Sex

  

0.731

 

 Male

20

18

  

 Female

19

20

  

BMI (kg/m2)

23.53 (4.29)

23.70(3.24)

0.109

 

ASA physical status

  

0.429

 

 I

0

0

  

 II

14

17

  

 III

25

21

  

Preoperative medical history

 Hypertension

15

12

0.527

 

 Diabetes mellitus

3

0

0.081

 

 Cerebrovascular accident

8

6

0.591

 

 Cerebral infarction

7

2

0.083

 

Active tobacco

15

18

0.430

 

Preoperative anxiety scores

3 (2–3)

3(2–3)

0.117

 

Surgery characteristics

 Surgery duration

118 (110–126)

116 (109.5–125)

0.713

 

 One-lung ventilation duration

100 (93–103)

96.5 (91.5–106)

0.510

 

 Anesthesia duration

137 (128–140)

135 (126.75–138.25)

0.196

 

Nodule characteristics

  

0.237

 

 Malignant

33

28

  

 Benign

6

10

  

Lobectomy locations

  

0.605

 

 Left upper lobe

7

12

0.165

 

 Left lower lobe

4

5

0.692

 

 Right upper lobe

15

11

0.377

 

 Right middle lobe

5

5

0.965

 

 Right lower lobe

8

5

0.389

 
  1. All values shown are mean (SD) or median (IQR) or n (%) as appropriate
  2. SD standard deviation, IQR inter-quartile range, BMI Body mass index, ASA American Society of Anesthesiologists